Oral drug shows promise type 1 diabetes trial

There are two basic delivery choices for psoriasis medications, says Kenneth Gordon, Professor of Dermatology at Northwestern University. While biologic therapies given as shots have higher response rates, new oral medications such as apremilast and tofacitinib work well, cost less, and may appeal to patients who don’t like injectibles.

Leave a Comment